Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study

Eckl-Dorna, J.; Fröschl, R.; Lupinek, C.; Kiss, R.; Gattinger, P.; Marth, K.; Campana, R.; Mittermann, I.; Blatt, K.; Valent, P.; Selb, R.; Mayer, A.; Gangl, K.; Steiner, I.; Gamper, J.; Perkmann, T.; Zieglmayer, P.; Gevaert, P.; Valenta, R.; Niederberger, V.

Published in

Wiley, Allergy, 5(73), p. 1003-1012, 2017

DOI: 10.1111/all.13343

Tools

Export citation

Search in Google Scholar

Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study

Journal article published in 2017 by J. Eckl-Dorna, R. Fröschl, C. Lupinek, R. Kiss, P. Gattinger, K. Marth, R. Campana, I. Mittermann, K. Blatt, P. Valent, R. Selb

, A. Mayer, K. Gangl, I. Steiner, J. Gamper and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study